Publikation

Can antiretroviral therapy be used to prevent sexual transmission of human immunodeficiency virus type 1?

Wissenschaftlicher Artikel/Review - 15.05.2002

Bereiche
PubMed
DOI

Zitation
Hosseinipour M, Cohen M, Vernazza P, Kashuba A. Can antiretroviral therapy be used to prevent sexual transmission of human immunodeficiency virus type 1?. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2002; 34:1391-5.
Art
Wissenschaftlicher Artikel/Review (Englisch)
Zeitschrift
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2002; 34
Veröffentlichungsdatum
15.05.2002
eISSN (Online)
1537-6591
Seiten
1391-5
Kurzbeschreibung/Zielsetzung

Approximately 5 million people annually are newly infected with human immunodeficiency virus (HIV). Although education, behavior modification, and promotion of condom use are effective transmission-prevention measures, the severity of the pandemic demands that all possible prevention strategies be explored. Antiretroviral therapy has the potential to decrease sexual transmission of HIV type 1 by reducing levels of HIV RNA and thus decreasing the risk that infected persons will transmit the disease or by its use as preexposure or postexposure prophylaxis. In this article, we explore the rationale for using antiretroviral therapy to prevent sexual transmission of HIV, as well as the limitations of this approach.